RxDoctor Payments Data

Julie Barone, DO

Surgery · Santa Maria, CANPI 1720110315

Payments from drug & device makers

$6,267in general payments, 2019–2025

Across 18 payments — averaging $348.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Focal Therapeutics, Inc.$4K
  • Carl Zeiss Meditec, Inc.$1K
  • Sirius Medical Systems$329
  • Biotissue Holdings Inc.$143
  • Merit Medical Systems Inc$123
  • Myriad Genetic Laboratories, Inc.$122
  • plus $321 from 6 others

What the payments were for

  • Travel & lodging$1,21454%
  • Food & beverage$1,05346%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Focal Therapeutics, Inc.2$4,016
Carl Zeiss Meditec, Inc.1$1,214
Sirius Medical Systems3$329
Biotissue Holdings Inc.1$143
Merit Medical Systems Inc1$123
Myriad Genetic Laboratories, Inc.4$122
Impedimed, Inc.1$117
Johnson & Johnson1$103
Bioptics, Inc.1$37
Endomagnetics Ltd1$26
Tactile Systems Technology Inc1$20
Covidien LP1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,267 in reported general payments places this provider in the 65th percentile of 2,363 surgery providers in California.

See all surgery providers in California

Medicare billing

Part B allowed, 2024
$89,548
Medicare patients
173
Services billed
414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl25$45

Paid to pharmacies, not to this prescriber.

Other surgery in Santa Maria

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →